valproic acid has been researched along with acetylcarnitine in 13 studies
*Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS. [MeSH]
*Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, A; Kobayashi, Y; Murakami, K; Nishida, N; Sugimoto, T; Woo, M | 1 |
| Glocker, FX; Jaksch, M; Ketelsen, UP; Kottlors, M; Lücking, CH; Weiner, S | 1 |
| Hasegawa, H; Norikura, R; Ohnishi, S; Okamura, N; Shimaoka, H | 1 |
| Caprioli, A; Coccurello, R; Ghirardi, O; Virmani, A | 1 |
| Bosboom, WM; Iannaccone, ST; van den Berg, LH; Vrancken, AF; Wadman, RI; Wokke, JH | 1 |
| Bosboom, WM; Iannaccone, ST; van den Berg, LH; van der Pol, WL; Vrancken, AF; Wadman, RI; Wokke, JH | 1 |
| Donzelli, M; Fischer-Barnicol, D; Krähenbühl, S; Morand, R; Mullen, PJ; Todesco, L | 1 |
| Fagiolino, P; González, R; Guevara, N; Maldonado, C; Queijo, C; Vázquez, M | 1 |
| Hibino, H; Inoue, Y; Matsumoto, H; Mikami, A; Mikami, K; Suzuki, H | 1 |
| Gomathi, S; Jayaseelan, S; Kokilavani, A; Kumudhavalli, MV; Rajesh, V; Vishali, K | 1 |
| Roghani, M; Sadr, SS; Sanaeierad, A; Zahedi, E | 1 |
| Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
2 review(s) available for valproic acid and acetylcarnitine
| Article | Year |
|---|---|
Drug treatment for spinal muscular atrophy types II and III.
Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyurea; Neuroprotective Agents; Phenylbutyrates; Randomized Controlled Trials as Topic; Spinal Muscular Atrophies of Childhood; Thyrotropin-Releasing Hormone; Valproic Acid | 2011 |
Drug treatment for spinal muscular atrophy types II and III.
Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyurea; Neuroprotective Agents; Phenylbutyrates; Randomized Controlled Trials as Topic; Spinal Muscular Atrophies of Childhood; Thyrotropin-Releasing Hormone; Valproic Acid | 2012 |
1 trial(s) available for valproic acid and acetylcarnitine
| Article | Year |
|---|---|
Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia.
Topics: Acetylcarnitine; Adolescent; Adult; Aged; Aged, 80 and over; Ammonia; Bipolar Disorder; Carnitine; Epilepsy; Female; Humans; Male; Middle Aged; Phenytoin; Valproic Acid | 2016 |
10 other study(ies) available for valproic acid and acetylcarnitine
| Article | Year |
|---|---|
Alterations of urinary acetylcarnitine in valproate-treated rats: the effect of L-carnitine supplementation.
Topics: Acetylcarnitine; Animals; Carnitine; Chromatography, Liquid; Drug Interactions; Injections, Intraperitoneal; Male; Mitochondria, Liver; Rats; Rats, Wistar; Valproic Acid | 1992 |
Valproic acid triggers acute rhabdomyolysis in a patient with carnitine palmitoyltransferase type II deficiency.
Topics: Acetylcarnitine; Acute Disease; Antimanic Agents; Bipolar Disorder; Carnitine O-Palmitoyltransferase; Humans; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Mitochondrial Diseases; Muscle, Skeletal; Mutation; Myoglobinuria; Rhabdomyolysis; Valproic Acid | 2001 |
Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid.
Topics: Acetylcarnitine; Algorithms; Amino Acid Transport Systems, Basic; Animals; Biological Transport, Active; Carnitine; Carrier Proteins; Enzyme Inhibitors; LLC-PK1 Cells; Pentanoic Acids; Swine; Valproic Acid | 2006 |
Valproate and acetyl-L-carnitine prevent methamphetamine-induced behavioral sensitization in mice.
Topics: Acetylcarnitine; Analysis of Variance; Animals; Behavior, Animal; Drug Administration Schedule; Drug Interactions; Male; Methamphetamine; Mice; Motor Activity; Neuroprotective Agents; Psychomotor Disorders; Time Factors; Valproic Acid | 2007 |
Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans.
Topics: Acetylcarnitine; Adult; Betaine; Biological Transport; Carnitine; Cell Line; Drug Administration Schedule; Female; HEK293 Cells; Homeostasis; Humans; Kidney Tubules, Proximal; Organic Cation Transport Proteins; Solute Carrier Family 22 Member 5; Valproic Acid | 2012 |
Effect of acetyl-l-carnitine in elderly patient who presented with hyperammonemia associated with administration of sodium valproate.
Topics: Acetylcarnitine; Aged; Female; GABA Agents; Humans; Hyperammonemia; Valproic Acid; Vitamin B Complex | 2017 |
Embryonic exposure to acetyl-L-carnitine protects against valproic acid-induced cardiac malformation in zebrafish model.
Topics: Acetylcarnitine; Animals; Carnitine; Heart; Valproic Acid; Zebrafish | 2023 |
Chronic acetyl-L-carnitine treatment alleviates behavioral deficits and neuroinflammation through enhancing microbiota derived-SCFA in valproate model of autism.
Topics: Acetylcarnitine; Animals; Autism Spectrum Disorder; Autistic Disorder; Encephalitis; Female; Microbiota; Neuroinflammatory Diseases; Pregnancy; Rats; Tumor Necrosis Factor-alpha; Valproic Acid | 2023 |
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |